Oral exposure of pigs to the mycotoxin deoxynivalenol does not modulate the hepatic albumin synthesis during a LPS-induced acute-phase reaction von Dänicke, Sven, Bannert, Erik, Tesch, Tanja, Kersten, Susanne, Frahm, Jana, Bühler, Susanne, Sauerwein, Helga, Görs, Solvig, Kahlert, Stefan, Rothkötter, Hermann-Josef, Metges, Cornelia C, Kluess, Jeannette

Volltext

Does chronic dietary exposure to the mycotoxin deoxynivalenol affect the porcine hepatic transcriptome when an acute-phase response is initiated through first or second-pass LPS ch... von Dänicke, Sven, Heymann, Ann-Katrin, Oster, Michael, Wimmers, Klaus, Tesch, Tanja, Bannert, Erik, Bühler, Susanne, Kersten, Susanne, Frahm, Jana, Kluess, Jeannette, Kahlert, Stefan, Rothkötter, Hermann-Josef, Billenkamp, Fabian

Volltext

Effects of deoxynivalenol-feed contamination on circulating LPS in pigs von Kahlert, Stefan, Renner, Lydia, Kluess, Jeannette, Frahm, Jana, Tesch, Tanja, Bannert, Erik, Kersten, Susanne, Dänicke, Sven, Rothkötter, Hermann-Josef

Volltext

Metabolic and hematological consequences of dietary deoxynivalenol interacting with systemic Escherichia coli lipopolysaccharide von Bannert, Erik, Tesch, Tanja, Kluess, Jeannette, Frahm, Jana, Kersten, Susanne, Kahlert, Stefan, Renner, Lydia, Rothkötter, Hermann-Josef, Dänicke, Sven

Volltext

Does Dietary Deoxynivalenol Modulate the Acute Phase Reaction in Endotoxaemic Pigs?--Lessons from Clinical Signs, White Blood Cell Counts, and TNF-Alpha von Tesch, Tanja, Bannert, Erik, Kluess, Jeannette, Frahm, Jana, Kersten, Susanne, Breves, Gerhard, Renner, Lydia, Kahlert, Stefan, Rothkötter, Hermann-Josef, Dänicke, Sven

Volltext

Chronic DON exposure and acute LPS challenge: effects on porcine liver morphology and function von Renner, Lydia, Kahlert, Stefan, Tesch, Tanja, Bannert, Erik, Frahm, Jana, Barta-Böszörményi, Anikó, Kluess, Jeannette, Kersten, Susanne, Schönfeld, Peter, Rothkötter, Hermann-Josef, Dänicke, Sven

Volltext

Plasma kinetics and matrix residues of deoxynivalenol (DON) and zearalenone (ZEN) are altered in endotoxaemic pigs independent of LPS entry site von Bannert, Erik, Tesch, Tanja, Kluess, Jeannette, Valenta, Hana, Frahm, Jana, Kersten, Susanne, Kahlert, Stefan, Renner, Lydia, Rothkötter, Hermann-Josef, Dänicke, Sven

Volltext

Prognostic Impact of Circulating Tumor Cells for Breast Cancer Patients Treated in the Neoadjuvant "Geparquattro" Trial von Riethdorf, Sabine, Müller, Volkmar, Loibl, Sibylle, Nekljudova, Valentina, Weber, Karsten, Huober, Jens, Fehm, Tanja, Schrader, Iris, Hilfrich, Jörn, Holms, Frank, Tesch, Hans, Schem, Christian, von Minckwitz, Gunter, Untch, Michael, Pantel, Klaus

Volltext

Neoadjuvant Chemotherapy and Bevacizumab for HER2-Negative Breast Cancer von von Minckwitz, Gunter, Eidtmann, Holger, Rezai, Mahdi, Fasching, Peter A, Tesch, Hans, Eggemann, Holm, Schrader, Iris, Kittel, Kornelia, Hanusch, Claus, Kreienberg, Rolf, Solbach, Christine, Gerber, Bernd, Jackisch, Christian, Kunz, Georg, Blohmer, Jens-Uwe, Huober, Jens, Hauschild, Maik, Fehm, Tanja, Müller, Berit Maria, Denkert, Carsten, Loibl, Sibylle, Nekljudova, Valentina, Untch, Michael

Volltext

Circulating Tumor Cells Predict Survival in Early Average-to-High Risk Breast Cancer Patients von RACK, Brigitte, SCHINDLBECK, Christian, FEHM, Tanja, SCHNEEWEISS, Andreas, LICHTENEGGER, Werner, BECKMANN, Matthias W, FRIESE, Klaus, PANTEL, Klaus, JANNI, Wolfgang, JÜCKSTOCK, Julia, ANDERGASSEN, Ulrich, HEPP, Philip, ZWINGERS, Thomas, FRIEDL, Thomas W. P, LORENZ, Ralf, TESCH, Hans, FASCHING, Peter A

Volltext

Detection and HER2 Expression of Circulating Tumor Cells: Prospective Monitoring in Breast Cancer Patients Treated in the Neoadjuvant GeparQuattro Trial von RIETHDORF, Sabine, MÜLLER, Volkmar, HILFRICH, Jörn, HOLMS, Frank, TESCH, Hans, EIDTMANN, Holger, UNTCH, Michael, VON MINCKWITZ, Gunter, PANTEL, Klaus, LILING ZHANG, RAU, Thomas, LOIBL, Sibylle, KOMOR, Martina, ROLLER, Marc, HUOBER, Jens, FEHM, Tanja, SCHRADER, Iris

Volltext

The impact of physical activity on progression-free and overall survival in metastatic breast cancer based on molecular subtype von Ziegler, Philipp, Hartkopf, Andreas D, Wallwiener, Markus, Häberle, Lothar, Kolberg, Hans-Christian, Hadji, Peyman, Tesch, Hans, Ettl, Johannes, Lüftner, Diana, Müller, Volkmar, Michel, Laura L, Belleville, Erik, Wimberger, Pauline, Hielscher, Carsten, Huebner, Hanna, Uhrig, Sabrina, Wurmthaler, Lena A, Hack, Carolin C, Mundhenke, Christoph, Kurbacher, Christian, Fasching, Peter A, Wuerstlein, Rachel, Untch, Michael, Janni, Wolfgang, Taran, Florin-Andrei, Lux, Michael P, Wallwiener, Diethelm, Brucker, Sara Y, Fehm, Tanja N, Schneeweiss, Andreas, Goossens, Chloë

Volltext

Gemcitabine as adjuvant chemotherapy in patients with high-risk early breast cancer-results from the randomized phase III SUCCESS-A trial von de Gregorio, Amelie, Haberle, Lothar, Fasching, Peter A., Mueller, Volkmar, Schrader, Iris, Lorenz, Ralf, Forstbauer, Helmut, Friedl, Thomas W. P., Bauer, Emanuel, de Gregorio, Nikolaus, Deniz, Miriam, Fink, Visnja, Bekes, Inga, Andergassen, Ulrich, Schneeweiss, Andreas, Tesch, Hans, Mahner, Sven, Brucker, Sara Y., Blohmer, Jens-Uwe, Fehm, Tanja N., Heinrich, Georg, Lato, Krisztian, Beckmann, Matthias W., Rack, Brigitte, Janni, Wolfgang

Volltext

Ki67 Measured after Neoadjuvant Chemotherapy for Primary Breast Cancer von VON MINCKWITZ, Gunter, SCHMITT, Wolfgang D, HILFRICH, Jörn, HUOBER, Jens, FEHM, Tanja, BARINOFF, Jana, RÜDIGER, Thomas, ERBSTOESSER, Erhard, FASCHING, Peter A, KARN, Thomas, MÜLLER, Volkmar, JACKISCH, Christian, LOIBL, Sibylle, DENKERT, Carsten, MÜLLER, Berit M, BLOHMER, Jens U, SINN, Bruno V, EIDTMANN, Holger, EIERMANN, Wolfgang, GERBER, Bernd, TESCH, Hans

Volltext

Prognostic effect of low-level HER2 expression in patients with clinically negative HER2 status von Hein, Alexander, Hartkopf, Andreas D., Emons, Julius, Lux, Michael P., Volz, Bernhard, Taran, Florin-Andrei, Overkamp, Friedrich, Hadji, Peyman, Tesch, Hans, Häberle, Lothar, Ettl, Johannes, Lüftner, Diana, Wurmthaler, Lena A., Wallwiener, Markus, Müller, Volkmar, Beckmann, Matthias W., Belleville, Erik, Wimberger, Pauline, Hielscher, Carsten, Kurbacher, Christian M., Wuerstlein, Rachel, Thomssen, Christoph, Untch, Michael, Fasching, Peter A., Janni, Wolfgang, Fehm, Tanja N., Wallwiener, Diethelm, Brucker, Sara Y., Schneeweiss, Andreas, Kolberg, Hans-Christian

Volltext

The effect of denosumab on disseminated tumor cells (DTCs) of breast cancer patients with neoadjuvant treatment: a GeparX translational substudy von Wimberger, Pauline, Blohmer, Jens-Uwe, Krabisch, Petra, Link, Theresa, Just, Marianne, Sinn, Bruno Valentin, Simon, Eike, Solbach, Christine, Fehm, Tanja, Denkert, Carsten, Kühn, Cristin, Rhiem, Kerstin, Tesch, Hans, Kümmel, Sherko, Petzold, Andrea, Stötzer, Oliver, Meisel, Cornelia, Kuhlmann, Jan Dominik, Nekljudova, Valentina, Loibl, Sibylle

Volltext

Mutations in BRCA1/2 and Other Panel Genes in Patients With Metastatic Breast Cancer -Association With Patient and Disease Characteristics and Effect on Prognosis von Fasching, Peter A., Yadav, Siddhartha, Hu, Chunling, Wunderle, Marius, Haeberle, Lothar, Hart, Steven N., Ruebner, Matthias, Polley, Eric C., Lee, Kun Y., Gnanaolivu, Rohan D., Hadji, Peyman, Huebner, Hanna, Tesch, Hans, Ettl, Johannes, Overkamp, Friedrich, Lux, Michael P., Ekici, Arif B., Volz, Bernhard, Uhrig, Sabrina, Lueftner, Diana, Wallwiener, Markus, Mueller, Volkmar, Belleville, Erik, Untch, Michael, Kolberg, Hans-Christian, Beckmann, Matthias W., Reis, Andre, Hartmann, Arndt, Janni, Wolfgang, Wimberger, Pauline, Taran, Florin-Andrei, Fehm, Tanja N., Wallwiener, Diethelm, Brucker, Sara Y., Schneeweiss, Andreas, Hartkopf, Andreas D., Couch, Fergus J.

Volltext

Heregulin (HRG) assessment for clinical trial eligibility testing in a molecular registry (PRAEGNANT) in Germany von Huebner, Hanna, Kurbacher, Christian M., Kuesters, Geoffrey, Hartkopf, Andreas D., Lux, Michael P., Huober, Jens, Volz, Bernhard, Taran, Florin-Andrei, Overkamp, Friedrich, Tesch, Hans, Haeberle, Lothar, Lueftner, Diana, Wallwiener, Markus, Mueller, Volkmar, Beckmann, Matthias W., Belleville, Erik, Ruebner, Matthias, Untch, Michael, Fasching, Peter A., Janni, Wolfgang, Fehm, Tanja N., Kolberg, Hans-Christian, Wallwiener, Diethelm, Brucker, Sara Y., Schneeweiss, Andreas, Ettl, Johannes

Volltext

BRCA1/2 Mutations and Bevacizumab in the Neoadjuvant Treatment of Breast Cancer: Response and Prognosis Results in Patients With Triple-Negative Breast Cancer From the GeparQuinto... von Fasching, Peter A, Loibl, Sibylle, Hu, Chunling, Hart, Steven N, Shimelis, Hermela, Moore, Raymond, Schem, Christian, Tesch, Hans, Untch, Michael, Hilfrich, Jörn, Rezai, Mahdi, Gerber, Bernd, Costa, Serban Dan, Blohmer, Jens-Uwe, Fehm, Tanja, Huober, Jens, Liedtke, Cornelia, Weinshilboum, Richard M, Wang, Liewei, Ingle, James N, Müller, Volkmar, Nekljudova, Valentina, Weber, Karsten E, Rack, Brigitte, Rübner, Matthias, von Minckwitz, Gunter, Couch, Fergus J

Volltext

Efficacy of neoadjuvant pertuzumab in addition to chemotherapy and trastuzumab in routine clinical treatment of patients with primary breast cancer: a multicentric analysis von Fasching, Peter A., Hartkopf, Andreas D., Gass, Paul, Häberle, Lothar, Akpolat-Basci, Leyla, Hein, Alexander, Volz, Bernhard, Taran, Florin-Andrei, Nabieva, Naiba, Pott, Birgit, Overkamp, Friedrich, Einarson, Hanna, Hadji, Peyman, Tesch, Hans, Ettl, Johannes, Lüftner, Diana, Wallwiener, Markus, Müller, Volkmar, Janni, Wolfgang, Fehm, Tanja N., Schneeweiss, Andreas, Untch, Michael, Pott, Dirk, Lux, Michael P., Geyer, Thomas, Liedtke, Cornelia, Seeger, Harald, Wetzig, Sarah, Hartmann, Arndt, Schulz-Wendtland, Rüdiger, Belleville, Erik, Wallwiener, Diethelm, Beckmann, Matthias W., Brucker, Sara Y., Kolberg, Hans-Christian

Volltext